Regeneron Pharmaceuticals Inc Recalls

1 recall found for Regeneron Pharmaceuticals Inc — July 2026.

Medications: 1

The recalls listed below are active notices associated with Regeneron Pharmaceuticals Inc in the FDA, NHTSA, USDA, and CPSC databases. None of the current recalls are classified as urgent. The current recall involves sterility concerns. Check the specific lot numbers, model numbers, or production date codes in each notice carefully — a recall typically covers specific production runs, not everything a manufacturer sells.

A manufacturer appearing in the recall database does not indicate an ongoing safety failure. High-volume companies with large product lines naturally appear more frequently. What matters is whether your specific product — identified by lot number, model number, or date code — is included in a recall notice.

Browse all medication recalls
NoticeMedications

Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL (50 mg/mL), For Intravenous Infusion After Dilution, Single-Dose Vial,

Regeneron Pharmaceuticals Inc

Lack of Assurance of Sterility

View recall →